ERK and MEK kinases as novel therapeutic targets in myeloproliferative neoplasms based on bypass MAPK pathway activation

Date Issued
2018
Publication Type
Conference Item
Subject(s)
Language(s)
en
Author(s)
Stivala, S
Baerenwaldt, A
Codilupi, T
Ghosh, N
Hao-Shen, H
Dirnhofer, S
Simillion, C
Chiu, S
Keller, M
Additional Credits
Journal
Swiss medical weekly
Publisher
EMH Schweizerischer Ärzteverlag
ISSN
1424-7860
Title of Event
Access(Rights)
metadata.only
Show full item